bromocriptine has been researched along with sch 23390 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Floresco, SB; St Onge, JR | 1 |
Robbins, TW; Winstanley, CA; Zeeb, FD | 1 |
Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
3 other study(ies) available for bromocriptine and sch 23390
Article | Year |
---|---|
Dopaminergic modulation of risk-based decision making.
Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Benzopyrans; Bromocriptine; Conditioning, Operant; Decision Making; Dextroamphetamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Naphthalenes; Oxazines; Piperazines; Pyridines; Pyrroles; Pyrrolidines; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reinforcement Schedule; Risk; Salicylamides | 2009 |
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bromocriptine; Choice Behavior; Conditioning, Operant; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Models, Animal; Piperazines; Pyridines; Quinpirole; Rats; Rats, Long-Evans; Reward; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Task Performance and Analysis | 2009 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |